OMass Therapeutics

OMass Therapeutics is a biotechnology company dedicated to developing drugs targeting highly validated ecosystems, such as membrane proteins or intracellular complexes. The company's unique OdyssION™ technology platform includes novel biochemical techniques, next-generation native mass spectrometry, and customized chemistry. OMass is advancing a range of small-molecule therapies for rare diseases and immune disorders, targeting solute carriers, complex-binding proteins, and GPCRs.